Novel method for preventing or treating M tuberculosis infection

Details for Australian Patent Application No. 2011224145 (hide)

Owner GlaxoSmithKline Biologicals S.A. Infectious Disease Research Institute (IDRI)

Inventors Coler, Rhea; Lobet, Yves; Reed, Steven

Agent Shelston IP

Pub. Number AU-A-2011224145

Parent 2006243357

Filing date 20 September 2011

Wipo publication date 13 October 2011

International Classifications

C07K 14/35 (2006.01) Peptides having more than 20 amino acids

A61K 39/04 (2006.01) Medicinal preparations containing antigens or antibodies - Mycobacterium, e.g. Mycobacterium tuberculosis

Event Publications

6 October 2011 Complete Application Filed

13 October 2011 Application Open to Public Inspection

  Published as AU-A-2011224145

1 March 2012 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Marchand, Martine

1 March 2012 Alteration of Name

  The name of the applicant has been altered to GlaxoSmithKline Biologicals S.A.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011224146-Image forming apparatus and image forming method

2011224144-Foamable alcoholic composition